Edition:
United Kingdom

Wacker Chemie AG (WCHG.DE)

WCHG.DE on Xetra

79.66EUR
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
€79.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
182,613
52-wk High
€176.80
52-wk Low
€73.52

Latest Key Developments (Source: Significant Developments)

Wacker Chemie Renames Newly Acquired Pharmaceutical Protein Production Facility In Netherlands
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Wacker Chemie AG ::NEWLY ACQUIRED PHARMACEUTICAL PROTEIN PRODUCTION SYNCO BIO PARTNERS B.V. IN THE NETHERLANDS IS NOW WACKER BIOTECH B.V..  Full Article

Wacker Chemie To Raise Prices For Silicone Rubber In Europe, Middle East And South America
Friday, 26 Oct 2018 

Oct 26 (Reuters) - Wacker Chemie AG ::TO RAISE PRICES FOR SILICONE RUBBER IN EUROPE, MIDDLE EAST AND IN SOUTH AMERICA AS OF NOVEMBER 1.TO RAISE PRICES FOR SILICONE RUBBER IN EUROPE, THE MIDDLE EAST AND IN SOUTH AMERICA.DEPENDING ON PRODUCT GROUP, REGION AND BUSINESS FIELD, THE PRICE INCREASE WILL RANGE UP TO 40 PERCENT.  Full Article

Wacker Chemie Affirms Guidance After 19 Pct Drop In Q3 EBITDA
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Wacker Chemie AG ::DGAP-NEWS: WACKER CHEMIE AG: AFTER FIRST NINE MONTHS, WACKER CONFIRMS FORECAST OF HIGHER SALES AND EBITDA FOR FULL-YEAR 2018.AS A RESULT, GROUP SALES FOR Q3 2018 COME IN AT EUR1.24 BILLION, DOWN 5 PERCENT YEAR OVER YEAR AND 7 PERCENT QUARTER OVER QUARTER.AT EUR242 MILLION, EBITDA DECREASES 19 PERCENT VERSUS LAST YEAR AND 7 PERCENT VERSUS A QUARTER AGO.NET INCOME FOR Q3 AMOUNTS TO EUR69 MILLION.NET INCOME FOR QUARTER AMOUNTED TO EUR68.9 MILLION.PROSPECTS REMAIN POSITIVE FOR THIS YEAR AND BEYOND.WACKER POLYSILICON USED MARKET SITUATION FOR INVENTORY REBUILDING, WHICH WILL ALLOW IT TO SUPPLY CUSTOMERS PROMPTLY ONCE DEMAND AND PRICES HAVE PICKED UP.WACKER SILICONES ANTICIPATES LIFTING ITS FULL-YEAR EBITDA SOMEWHAT HIGHER THAN PROJECTED.SEES WACKER POLYSILICON LIKELY POSTING YEAR-OVER-YEAR DECLINE OF AROUND 25 PERCENT IN FULL-YEAR SALES AND EBITDA.  Full Article

Wacker Chemie Wins FDA OK To Make Drug Substance In Chiesi's Retavase
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Wacker Chemie AG ::SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI‍​.  Full Article

Wacker Chemie Supervisory Board Extends Contract Of CEO Rudolf Staudigl
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - WACKER CHEMIE AG ::DGAP-NEWS: WACKER CHEMIE AG: SUPERVISORY BOARD EXTENDS THE CONTRACTS OF CEO RUDOLF STAUDIGL AND EXECUTIVE BOARD MEMBER CHRISTIAN HARTEL.RUDOLF STAUDIGL RE-APPOINTED AS PRESIDENT & CEO UNTIL 2021.  Full Article

Siltronic ups outlook for sales, EBITDA margin
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Siltronic Ag :Says ‍production of 300 mm and 200 mm wafers has already been fully loaded for five consecutive quarters​.Says ‍q3 sales up 9 percent on previous quarter​.Says ‍q3 ebitda up 46 percent on previous quarter​.Says ‍q3 ebitda margin of 35 percent​.Says ‍forecast raised slightly​.Says ‍slightly raises 2017 forecast and now expects sales of at least eur 1.16 billion and an ebitda margin of at least 29 percent​.  Full Article

Wacker Chemie says Wacker Polymers to raise prices for dispersible powders‍​
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - WACKER CHEMIE AG ::WACKER POLYMERS TO RAISE PRICES FOR DISPERSIBLE POWDERS‍​.EFFECTIVE NOVEMBER 1, 2017, PRICES WILL BE INCREASED BY SEVEN PERCENT, OR AS CUSTOMER CONTRACTS ALLOW.  Full Article

Photo

Strong earnings from ING, BT help European shares to two-week high

MILAN/LONDON European shares hit a two-week high on Thursday as strong results from Dutch bank ING and UK telecoms group BT helped offset a disappointing update from Credit Suisse, and ASM International brought some cheer to chipmakers. | Video